About this medicine
- Approved name
- Inhaled corticosteroids containing medicinal products indicated in the treatment of chronic obstructive pulmonary disease
- International non-proprietary name (INN) or common name
- beclometasone
- budesonide
- flunisolide
- fluticasone propionate
- fluticasone furoate
- Class
- -
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-31/1415
- Type
- Article 31 referrals
This type of referral is triggered when the interest of the Union is involved, following concerns relating to the quality, safety or efficacy of a medicine or a class of medicines.
- Authorisation model
- Centrally and nationally authorised products (mixed)
- Decision making model
- PRAC-CHMP-EC
Key dates and outcomes
- Procedure start date
- 07/05/2015
- PRAC recommendation date
- 17/03/2016
- CHMP opinion date
- 28/04/2016
- EC decision date
- 29/06/2016
- Outcome
- Variation